Now closed –Â SUCCESSOR-1 trial
You can watch a very short video about it and results so far here https://www.youtube.com/watch?v=gbi9fHdmxmQ
The trial is Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) versus Pomalidomide, Bortezomib and Dexamethasone (PVd) for patients with relapsed or refractory multiple myeloma. You can read more about the trial, including the sites, here: https://clinicaltrials.gov/study/NCT05519085
The trial was at three sites in New Zealand (Dunedin, Tauranga and Auckland hospitals). To be eligible you needed to have received between 1 to 3 prior lines of therapy, have had prior lenalidomide exposure and couldnot have had pomalidomide before.
